Moneycontrol Presented by Motilal Oswal
Days hours minutes
Nerolac
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance
Indiabulls
DHFL

Co-Presenting Sponsor

Capital Trade

Powered by

Godrej

Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
Close Ad
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Yearly Results - Panacea Biotec

Panacea Biotec

BSE: 531349|NSE: PANACEABIO|ISIN: INE922B01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 23, 16:00
318.35
29.9 (10.37%)
VOLUME 458,989
LIVE
NSE
Jan 23, 15:59
318.25
29.55 (10.24%)
VOLUME 2,692,342
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Yearly Results of Panacea Biotec

------------------- in Rs. Cr. -------------------
Mar '17 Mar '16 Mar '15 Mar '14 Mar '13
Net Sales/Income from operations 530.09 619.66 643.24 467.14 530.42
Other Operating Income -- 27.24 35.96 35.89 65.50
Total Income From Operations 530.09 646.90 679.20 503.03 595.92
EXPENDITURE
Consumption of Raw Materials 157.02 168.82 241.42 196.58 236.37
Purchase of Traded Goods 21.62 24.02 20.79 22.39 23.26
Increase/Decrease in Stocks -9.80 21.51 26.39 -10.89 0.29
Power & Fuel -- -- -- -- --
Employees Cost 133.38 139.80 133.23 142.73 137.23
Depreciation 65.71 71.32 65.74 68.80 83.54
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 159.29 180.24 191.06 246.71 263.33
P/L Before Other Inc. , Int., Excpt. Items & Tax 2.87 41.19 0.57 -163.29 -148.10
Other Income 52.33 25.56 28.05 11.64 5.43
P/L Before Int., Excpt. Items & Tax 55.20 66.75 28.62 -151.65 -142.67
Interest 101.44 115.00 91.96 145.79 113.79
P/L Before Exceptional Items & Tax -46.24 -48.25 -63.34 -297.44 -256.46
Exceptional Items -37.54 49.65 -- 297.02 5.83
P/L Before Tax -83.78 1.40 -63.34 -0.42 -250.63
Tax 2.47 0.53 1.89 -- -20.50
P/L After Tax from Ordinary Activities -86.25 0.87 -65.23 -0.42 -230.13
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period -86.25 0.87 -65.23 -0.42 -230.13
Equity Share Capital 6.13 6.13 6.13 6.13 6.13
Reserves Excluding Revaluation Reserves 442.09 517.60 107.19 172.96 182.82
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS -14.07 0.14 -10.64 -0.07 -37.57
Diluted EPS -14.07 0.14 -10.64 -0.07 -37.57
EPS After Extra Ordinary
Basic EPS -14.07 0.14 -10.64 -0.07 -37.57
Diluted EPS -14.07 0.14 -10.64 -0.07 -37.57
Public Share Holding
No Of Shares (Crores) -- -- 1.56 1.54 1.54
Share Holding (%) -- -- 25.51 25.19 25.19
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- 1.60 -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- 35.08 -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- 26.13 -- --
b) Non-encumbered
- Number of shares (Crores) -- -- 2.96 4.58 4.58
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- 64.93 100.00 100.00
- Per. of shares (as a % of the total Share Cap. of the company) -- -- 48.38 74.81 74.81
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for panaceabiotec
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.